Journal of Food and Nutrition Research
ISSN (Print): 2333-1119 ISSN (Online): 2333-1240 Website: https://www.sciepub.com/journal/jfnr Editor-in-chief: Prabhat Kumar Mandal
Open Access
Journal Browser
Go
Journal of Food and Nutrition Research. 2024, 12(11), 471-481
DOI: 10.12691/jfnr-12-11-1
Open AccessArticle

Cissus Qadrangularis (L.) Stem Loaded Solid Lipid Nanoparticles Stimulate Osteogenic Differentiation Via Bone Morphogenic Protein-6 and Runt-related Transcription Factor 2 (RUNX2) in Human Mesenchymal Stem Cells

P. Subash-Babu1, , Nada Al Saran1 and Ali A Alshatwi1,

1Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, P. O. Box 2460, Riyadh-11451, Saudi Arabia

Pub. Date: November 06, 2024

Cite this paper:
P. Subash-Babu, Nada Al Saran and Ali A Alshatwi. Cissus Qadrangularis (L.) Stem Loaded Solid Lipid Nanoparticles Stimulate Osteogenic Differentiation Via Bone Morphogenic Protein-6 and Runt-related Transcription Factor 2 (RUNX2) in Human Mesenchymal Stem Cells. Journal of Food and Nutrition Research. 2024; 12(11):471-481. doi: 10.12691/jfnr-12-11-1

Abstract

The current study aimed to explore the role of Cissus quadrangularis (L.) stem on osteogenic differentiation of human mesenchymal stem cells (hMSCs) and their application in bone regeneration. Orally administered natural products and its bioactive compounds often results in poor absorption, low solubility, and restricted bioavailability due to their vulnerability to intestinal hydrolytic and enzymatic degradation. To overcome these challenges, bioactive compounds extracted from C. quadrangularis were fabricated into solid lipid nanoparticles (CQ-SLNp) to enhance bioavailability. MTT assay confirmed that the CQ-SLNp found with safe and significantly increased hMSCs proliferation and IC25 was identified. The impact of CQ-SLNp on stimulation of osteogenic differentiation in hMSCs at the lowest concentration was evaluated and compared to osteogenic standard medium alone after 4, 10 and 14 days, according to alkaline phosphatase (ALP) activity and alizarin red staining (ALZ) analysis. Bone morphogenic protein-receptor (BMPr) and Runt-related transcription factor 2 (RUNX2) associated mRNA levels has been analyzed. CQ-SLNp increased ALZ intensity and ALP activity. BMPr, RUNX2 and Wnt/β-catenin expressions found to be increased in osteogenesis induced hMSCs after 10 days compared to negative control. Although, the osteogenic differentiation was more effective in CQ-SLNp treatment when compared to CQ alone treated cells. We observed enhanced osteogenesis in CQ-SLNp alone treated hMSCs than standard differentiation medium. Taken together, the observed finding suggests that CQ-SLNp exhibited bioavailability and induced osteogenic differentiation of hMSCs, indicative of their potential applications for bone remodeling applications.

Keywords:
Osteoarthritis C. quadrangularis solid lipid nanoparticles bone morphogenic factors osteogenesis

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Hemmatian H, Bakker AD, Klein-Nulend J, van Lenthe GH. Aging, Osteocytes, and Mechanotransduction. In Current Osteoporosis Reports 2017; 15(5).
 
[2]  Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA. Local communication on and within bone controls bone remodeling. In Bone 2009; 44(6).
 
[3]  Chiba K, Nango N, Kubota S, Okazaki N, Taguchi K, et al. Relationship between microstructure and degree of mineralization in subchondral bone of osteoarthritis: A synchrotron radiation μCT study. Journal of Bone and Mineral Research 2012; 27(7).
 
[4]  Palumbo C, Ferretti M. The osteocyte: From “prisoner” to “orchestrator.” In journal of functional morphology and kinesiology 2021; 6(1).
 
[5]  Ten Dijke P, Krause C, De Gorter DJJ, Löwik CWGM, Van Bezooijen R L. Osteocyte-derived sclerostin inhibits bone formation: Its role in bone morphogenetic protein and Wnt signaling. Journal of bone and joint surgery 2008; 90(1).
 
[6]  Ling L, Dombrowski C, Foong KM, Haupt LM, Stein GS, et al. Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway. Journal of biological chemistry, 2010; 285(34).
 
[7]  Matta C, Szűcs-Somogyi C, Kon E, Robinson D, Neufeld T, et al. Osteogenic differentiation of human bone marrow-derived mesenchymal stem cells is enhanced by an aragonite scaffold. Differentiation 2019; 107.
 
[8]  Maes C, Kobayashi T, Selig MK, Torrekens S, Roth SI, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Developmental cell 2010; 19(2).
 
[9]  Sharifi S, Moghaddam FA, Abedi A, Maleki Dizaj S, Ahmadian S, et al. Phytochemicals impact on osteogenic differentiation of mesenchymal stem cells. In BioFactors 2020; 46(6).
 
[10]  Wu Y, Liu Y, Xu Y, Zheng A, Du J, Cao L, Shi J, Jiang X. Bioactive natural compounds as potential medications for osteogenic effects in a molecular docking approach. Frontiers in pharmacology 2022; 13, 955983.
 
[11]  Srinaath N, Balagangadharan K, Pooja V, Paarkavi U, Trishla A, Selvamurugan, N. Osteogenic potential of zingerone, a phenolic compound in mouse mesenchymal stem cells. BioFactors (Oxford, England) 2019; 45(4), 575–582.
 
[12]  Zhang P, Dai KR, Yan SG, Yan WQ, Zhang C, Chen DQ, Xu B, Xu ZW. Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. European journal of pharmacology 2009; 607(1-3), 1–5.
 
[13]  Badawi N, El-Say K, Attia D, El-Nabarawi M, Elmazar M, Teaima M. Development of pomegranate extract-loaded solid lipid nanoparticles: quality by design approach to screen the variables affecting the quality attributes and characterization. ACS Omega 2020; 5(34), 21712–21721.
 
[14]  Bharali DJ, Siddiqui IA, Adhami VM, Chamcheu JC, Aldahmash AM, Mukhtar H, Mousa SA. Nanoparticle delivery of natural products in the prevention and treatment of cancers: Current status and future prospects. In cancers 2011; 3(4).
 
[15]  Mohseni R, Arabsadeghabadi Z, Ziamajidi N, Abbasalipourkabir R, Rezaeifarimani A. Oral administration of resveratrol-loaded solid lipid nanoparticle improves insulin resistance through targeting expression of snare proteins in adipose and muscle tissue in rats with type 2 diabetes. Nanoscale research letters 2019; 14: 227.
 
[16]  Xue M, Zhang L, Yang MX, Zhang W, Li XM, et al. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice. International journal of nanomedicine 2015; 10.
 
[17]  Bose S, Sarkar N. Natural Medicinal Compounds in Bone Tissue Engineering. Trends in biotechnology 2020; 38(4): 404–417.
 
[18]  Mohammadzadeh M, Zarei M, Abbasi H, Webster TJ, Beheshtizadeh N. Promoting osteogenesis and bone regeneration employing icariin-loaded nanoplatforms. Journal of biological engineering 2024; 18(1): 29.
 
[19]  Khezri K, Maleki DS, Rahbar Saadat Y, Sharifi S, Shahi S, Ahmadian E, Eftekhari A, Dalir Abdolahinia E, Lotfipour F. Osteogenic Differentiation of Mesenchymal Stem Cells via Curcumin-Containing Nanoscaffolds. Stem cells international 2021; 1520052.
 
[20]  Brahmkshatriya H, Shah K, Ananthkumar G, Brahmkshatriya M. Clinical evaluation of Cissus quadrangularis as osteogenic agent in maxillofacial fracture: A pilot study. AYU (An International Quarterly Journal of Research in Ayurveda) 2015; 36(2).
 
[21]  Bloomer RJ, Farney TM, McCarthy CG, Lee SR. Cissus quadrangularis reduces joint pain in exercise-trained men: a pilot study. The physician and sports medicine 2013; 41(3).
 
[22]  Bhujade A, Talmale S. In vivo studies on antiarthritic activity of Cissus quadrangularis against adjuvant induced arthritis. Journal of Clinical & Cellular Immunology 2015; 6(03).
 
[23]  Potu BK, Bhat KM, Rao MS, Nampurath GK, Chamallamudi MR, Nayak SR, Muttigi MS. Petroleum ether extract of Cissus quadrangularis (Linn.) enhances bone marrow mesenchymal stem cell proliferation and facilitates osteoblastogenesis. Clinics (Sao Paulo, Brazil) 2009; 64(10): 993–998.
 
[24]  Nørgaard R, Kassem M, Rattan SIS. Heat shock-induced enhancement of osteoblastic differentiation of hTERT-immortalized mesenchymal stem cells. Annals of the new york academy of sciences 2006; 1067 (1).
 
[25]  Yuan JS, Reed A, Chen F, Stewart CN. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006; 7.
 
[26]  Kim H.-Y. Analysis of variance (ANOVA) comparing means of more than two groups. Restorative dentistry & endodontics 2014; 39(1).
 
[27]  Charnock C, Finsrud T. Combining esters of para-hydroxy benzoic acid (parabens) to achieve increased antimicrobial activity. Journal of clinical pharmacy and therapeutics 2007; 32(6).
 
[28]  Mishra DK, Dhote V, Bhatnagar P, Mishra PK. Engineering solid lipid nanoparticles for improved drug delivery: Promises and challenges of translational research. In drug delivery and translational research 2012; 2(4).
 
[29]  Galán A, Moreno L, Párraga J, Serrano Á, Sanz MJ, et al. Novel isoquinoline derivatives as antimicrobial agents. Bioorganic and medicinal chemistry, 2013; 21(11).
 
[30]  Xia M, Liu L, Qiu R, Li M, Huang W, et al. Anti-inflammatory and anxiolytic activities of Euphorbia hirta extract in neonatal asthmatic rats. AMB Express 2018; 8(1).
 
[31]  Rathish IG, Javed K, Ahmad S, Bano S, Alam MS, et al. Synthesis and antiinflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide. Bioorganic and medicinal chemistry letters 2009; 19(1).
 
[32]  Ju L, Bode JW. Amide Formation by decarboxylative condensation of hydroxylamines and α-Ketoacids: N -[(1 S )-1 Phenylethyl]-Benzeneacetamide . In organic syntheses. 2010; 87: 218–225.
 
[33]  Zhang DQ, Tan XF, Tian H, Liu QM, Peng WX. Pyrolysis- GC/MS determination of biomedical components of the pyrolyzate from fruit hull and kernel hull of Camellia oleifera fruit. 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE) 2008.
 
[34]  Wu YQ, Peng WX, Song Y, Qing Y, Li S, He W. Determination of biomedicine components of Dinochloa puberula McClure by Py-GC/MS. 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE) 2008.
 
[35]  Mondal S, Rahaman CH. Studies in pharmacognostic characters of the climber Erycibe paniculata Roxb. of Convolvulaceae. Journal of medicinal plants studies 2020;8(2).
 
[36]  Hossain MA, Al-Toubi WAS, Weli AM, Al-Riyami QA, Al-Sabahi JN. Identification and characterization of chemical compounds in different crude extracts from leaves of Omani neem. Journal of taibah university for science 2013; 7(4).
 
[37]  Adebiyi JA, Njobeh PB, Adebo OA, Kayitesi E. Metabolite profile of Bambara groundnut (Vigna subterranea) and dawadawa (an African fermented condiment) investigation using gas chromatography high resolution time-of-flight mass spectrometry (GC-HRTOF-MS). Heliyon 2021; 7(4).
 
[38]  Cheng MC, Ker YB, Yu TH, Lin L, Peng RY, Peng CH. Chemical synthesis of 9(Z)-octadecenamide and its hypolipidemic effect: A bioactive agent found in the essential oil of mountain celery seeds. Journal of agricultural and food chemistry 2010; 58(3).
 
[39]  Zahan MN, Hasan M, Mallik S, Hashim MA, Juyena NS. Effect of Cissus quadrangularis on fracture healing in laboratory animal. Journal of health & biological sciences 2022; 10(1).
 
[40]  Hajiali H, Ouyang L, Llopis-Hernandez V, Dobre O, Rose FRAJ. Review of emerging nanotechnology in bone regeneration: Progress, challenges, and perspectives. In Nanoscale 2021; 13(23).
 
[41]  Cheng H, Chawla A, Yang Y, Li Y, Zhang J, Jang HL, Khademhosseini A. Development of nanomaterials for bone-targeted drug delivery. In Drug Discovery Today 2017; 22(9).
 
[42]  Chen G, Deng C, Li YP. TGF-β and BMP signaling in osteoblast differentiation and bone formation. In international journal of biological sciences 2012; 8(2).
 
[43]  Lee K-S, Kim H-J, Li Q-L, Chi X-Z, Ueta C, et al. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Molecular and Cellular Biology 2000; 20(23).
 
[44]  Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, et al. Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML Factors. In critical reviews in eukaryotic gene expression 2004; 14(1–2).
 
[45]  Schroeder TM, Jensen ED, Westendorf JJ. Runx2: A master organizer of gene transcription in developing and maturing osteoblasts. In Birth Defects Research Part C - Embryo Today: Reviews 2005; 75(3).
 
[46]  Mohseni R, Arabsadeghabadi Z, Ziamajidi N, Abbasalipourkabir R, Rezaeifarimani A. Oral administration of resveratrol-loaded solid lipid nanoparticle improves insulin resistance through targeting expression of snare proteins in adipose and muscle tissue in rats with Type 2 Diabetes. Nanoscale research letters 2019; 14: 227.
 
[47]  Parvathi K, Krishnan AG, Anitha A, Jayakumar R, Nair MB. Poly(L-lactic acid) nanofibers containing Cissus quadrangularis induced osteogenic differentiation in vitro. International journal of biological macromolecules 2018; 110.
 
[48]  Tamburaci S, Kimna C, Tihminlioglu F. Novel phytochemical Cissus quadrangularis extract–loaded chitosan/Na-carboxymethyl cellulose–based scaffolds for bone regeneration. Journal of bioactive and compatible polymers 2018; 33(6).
 
[49]  Hong G, He X, Shen Y, Chen X, Yang F, et al. Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss. Stem cell research and therapy 2019; 10(1).
 
[50]  Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. In nature medicine 2013; 19(2).
 
[51]  Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ. Update on Wnt signaling in bone cell biology and bone disease. In Gene 2012; 492(1).
 
[52]  Liu X, Kim JH, Wang J, Chen X, Zhang H, et al. Wnt signaling in bone formation and its therapeutic potential for bone diseases. In therapeutic advances in musculoskeletal disease 2013; 5(1).
 
[53]  Hoeppner LH, Secreto FJ, Westendorf JJ. Wnt signaling as a therapeutic target for bone diseases. In expert opinion on therapeutic targets 2009; 13(4).
 
[54]  Stohs SJ, Ray SD. A review and evaluation of the efficacy and safety of Cissus quadrangularis extracts. Phytother research 2013; 27(8): 1107-14.
 
[55]  Rao MS, Bhagath KP, Narayana SVB, Gopalan KN. Cissus quadrangularis plant extract enhances the development of cortical bone and trabeculae in the fetal femur. Pharmacologyonline 2007; 3.
 
[56]  Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PVN, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. Journal of biological chemistry 2005; 280(39).
 
[57]  Brahmkshatriya HR, Shah KA, Ananthkumar GB, Brahmkshatriya MH. Clinical evaluation of Cissus quadrangularis as osteogenic agent in maxillofacial fracture: A pilot study. Ayuurvedic 2015; 36(2): 169-73.
 
[58]  Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, et al. β-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. Journal of cellular biochemistry 2005; 94(2).
 
[59]  Hess K, Ushmorov A, Fiedler J, Brenner RE, Wirth T. TNFα promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-κB signaling pathway. Bone 2009; 45(2).
 
[60]  Filippi M, Born G, Felder-Flesch D, Scherberich A. Use of nanoparticles in skeletal tissue regeneration and engineering. Histology and histopathology 2020; 35(4).
 
[61]  Walmsley GG, McArdle A, Tevlin R, Momeni A, Atashroo D, et al. Nanotechnology in bone tissue engineering. In Nanomedicine: Nanotechnology, biology, and medicine 2015; 11(5).
 
[62]  Tautzenberger A, Kovtun A, Ignatius A. Nanoparticles and their potential for application in bone. In International journal of nanomedicine 2012; 7.
 
[63]  Barry M, Pearce H, Cross L, Tatullo M, Gaharwar AK. Advances in Nanotechnology for the Treatment of Osteoporosis. In current osteoporosis reports 2016; 14(3).